太古集團捐款1,550萬元助香港社區抗疫
太古集團表示,第五波疫情肆虐,其慈善信託基金(太古基金)的社區計劃「信望未來」捐款1,550萬元,協助弱勢社群渡過逆境。連同過去支援疫情的多個捐助項目,太古基金目前的抗疫捐款總額將超過4,800萬元。
集團指,「信望未來」的最新項目於3月啟動,將捐助1,550萬元協助最有需要的人士,為弱勢社群提供因疫情而未能得到的適切服務,協助他們維持生活所需。項目包括捐款900萬元,支援香港社會服務聯會超過30家非牟利機構成員,向弱勢社群提供適切服務;捐款350萬元,派發熱食飯盒、易於保存的主要食糧、食物及清潔衛生用品予長者、街道清潔工友及難民等弱勢社群等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.